BIO-TECHNE paid its 5 named executives $23.1M in total in FY2025 (Jun). CEO Kim Kelderman was paid $8.2M of that.
Pay$100 in the stock at the end of FY22 → $68
Pay of each named executive
Kim KeldermanPresident and CEO
| FY2025 (Jun) | ||||||
| FY2023 (Jun) |
2 years
James HippelExecutive Vice President and CFO
| FY2025 (Jun) | ||||||
| FY2023 (Jun) |
2 years
William GeistPresident, Protein Sciences
| FY2025 (Jun) | ||||||
| FY2023 (Jun) | ||||||
| FY2022 (Jun) | ||||||
| FY2021 (Jun) |
4 years
Matthew McManusPresident, Diagnostics and Spatial Biology
| FY2025 (Jun) | ||||||
| FY2023 (Jun) | ||||||
| FY2022 (Jun) |
3 years
Shane BohnenSenior Vice President and General Counsel
| FY2025 (Jun) | ||||||
| FY2023 (Jun) | ||||||
| FY2022 (Jun) | ||||||
| FY2021 (Jun) |
4 years
CEO pay against the pay peers
In FY2025 (Jun), the median CEO pay of the 3 peers with pay on file was $18.9M. The CEO of BIO-TECHNE was paid $8.2M, 57% below the median.
- 1Align Technology
- 2Insulet
- 3Revvity
- 4BIO-TECHNEThis company
- 5Alkermes plcNot disclosed
- 6Avantor, Inc.Not disclosed
- 7Bio-Rad Laboratories, Inc.Not disclosed
- 8EXACT Sciences CorporationNot disclosed
- 9Globus Medical, Inc.Not disclosed
- 10Haemonetics CorporationNot disclosed
- 11Integra LifeSciences Holdings CorpNot disclosed
- 12Masimo CorporationNot disclosed
- 13Natera, Inc.Not disclosed
- 14Penumbra, Inc.Not disclosed
- 15QIAGEN N.V.Not disclosed
- 16QuidelOrtho CorporationNot disclosed
- 17Repligen CorporationNot disclosed
- 18Teleflex Inc.Not disclosed
- 19Waters Corp.Not disclosed
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.